Redundancy of mammalian proteasome beta subunit function during endoplasmic reticulum associated degradation

Biochemistry. 2001 Nov 6;40(44):13397-405. doi: 10.1021/bi011322y.

Abstract

Misfolded proteins in the endoplasmic reticulum (ER) are degraded by N-terminal threonine proteases within the 26S proteasome. Each protease is formed by an activated beta subunit, beta5/X, beta1/Y, or beta2/Z, that exhibits chymotrypsin-like, peptidylglutamyl-peptide hydrolyzing, or trypsin-like activity, respectively. Little is known about the relative contribution of specific beta subunits in the degradation of endogenous protein substrates. Using active site proteasome inhibitors and a reconstituted degradation system, we now show that all three active beta subunits can independently contribute to ER-associated degradation of the cystic fibrosis transmembrane conductance regulator (CFTR). Complete inactivation (>99.5%) of the beta5/X subunit decreased the rate of ATP-dependent conversion of CFTR to trichloroacetic acid soluble fragments by only 40%. Similarly, proteasomes containing only active beta1/Y or beta2/Z subunits degraded CFTR at approximately 50% of the rate observed for fully functional proteasomes. Simultaneous inhibition (>93%) of all three beta subunits blocked CFTR degradation by approximately 90%, and inhibition of both protease and ATPase activities was required to completely prevent generation of small peptide fragments. Our results demonstrate both a conserved hierarchy (ChT-L > PGPH > or = T-L) as well as a redundancy of beta subunit function and provide insight into the mechanism by which active site proteasome inhibitors influence degradation of endogenous protein substrates at the ER membrane.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Animals
  • Biological Transport
  • Cell-Free System
  • Cysteine Endopeptidases / metabolism*
  • Cystic Fibrosis Transmembrane Conductance Regulator / metabolism*
  • Endoplasmic Reticulum / drug effects
  • Endoplasmic Reticulum / metabolism*
  • Glycerol / pharmacology
  • Glycosylation
  • Hemin / pharmacology
  • Humans
  • In Vitro Techniques
  • Intracellular Membranes / drug effects
  • Intracellular Membranes / metabolism*
  • Lactones / pharmacology
  • Leupeptins / pharmacology
  • Lipid Bilayers / metabolism
  • Multienzyme Complexes / metabolism*
  • Proteasome Endopeptidase Complex
  • Protein Subunits
  • Rabbits
  • Reticulocytes / drug effects
  • Reticulocytes / metabolism
  • Trypsin / pharmacology
  • Ubiquitins / metabolism

Substances

  • CFTR protein, human
  • Lactones
  • Leupeptins
  • Lipid Bilayers
  • Multienzyme Complexes
  • Protein Subunits
  • Ubiquitins
  • Cystic Fibrosis Transmembrane Conductance Regulator
  • Hemin
  • Adenosine Triphosphate
  • Trypsin
  • Cysteine Endopeptidases
  • Proteasome Endopeptidase Complex
  • Glycerol
  • benzyloxycarbonylleucyl-leucyl-leucine aldehyde